Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

9,878 total articles

Provident Financial Executive Chairman Disposes of $24,622 in Shares

Provident Financial Executive Chairman Disposes of $24,622 in Shares

Provident Financial Services Executive Chairman Christopher P. Martin sold 1,050 shares on February 5, 2026, at $23.45 per share for proceeds of $24,622. The transaction occurs while the bank's shares trade close to a 52-week high and after the company reported fourth-quarter 2025 results that topped analyst expectations for both EPS and revenue.

Horizon Kinetics Adds One Share to Its Texas Pacific Land Stake; TPL Reports Q3 Miss, Announces Data Center Partnership

Horizon Kinetics Adds One Share to Its Texas Pacific Land Stake; TPL Reports Q3 Miss, Announces Data Center Partnership

Horizon Kinetics Asset Management LLC, a roughly 10% holder of Texas Pacific Land Corp (TPL), recorded a purchase of a single common share on February 5, 2026, at $341.52. The firm now directly holds 3,479,367 shares. Separately, Texas Pacific Land released Q3 2025 results that fell short of analyst expectations and disclosed a strategic partnershi…

Graco Executive Disposes $195,759 in Stock; Also Exercises Options

Graco Executive Disposes $195,759 in Stock; Also Exercises Options

Kathryn L. Schoenrock, Executive Vice President and Chief Information Officer of Graco Inc (NYSE: GGG), sold 2,223 shares on February 2, 2026, for $195,759 and exercised options for 3,336 shares the same day. Graco reported fourth-quarter 2025 EPS of $0.77 and revenue of $593.2 million, slightly above expectations, with management citing acquisitio…

Allogene CEO Executes Stock Sale to Cover RSU Taxes as Company Highlights Clinical and Commercial Progress

Allogene CEO Executes Stock Sale to Cover RSU Taxes as Company Highlights Clinical and Commercial Progress

Allogene Therapeutics President and CEO Chang David D. sold 95,269 shares on February 2, 2026 to meet tax withholding tied to vested restricted stock units, a transaction that generated $171,484. The move occurred against a backdrop of strong recent share performance, a favorable arbitration ruling on the company’s cell therapy, an earnings beat fo…

Warburg Pincus Disposes $237 Million Stake in Banc of California; Analysts React to Quarterly Strength

Warburg Pincus Disposes $237 Million Stake in Banc of California; Analysts React to Quarterly Strength

Warburg Pincus sold 11,849,999 shares of various Banc of California equity classes on February 2, 2026, at $20.00 per share, generating proceeds of $237,000,000. The transaction consisted of Voting Common, Non-Voting Common Equivalent and NVCE Stock. Banc of California’s recent fourth-quarter results outpaced analyst expectations, prompting several…